SOCS3 and Alzheimer disease: However, in contrast to these results, reduced SOCS1 and SOCS3 were found in APP/PS1 mice, accompanied by increased phosphorylation of JAK2, STAT1, and STAT3 (Ruganzu et al., 2021), suggesting that the SOCS signaling pathway is impaired in AD progression.